By InvitationNot Applicable

MRI-guided Locoregional SBRT Prostate Program

Spain40 participantsStarted 2025-10-01

Plain-language summary

The implementation of Magnetic Resonance Image Guided Radiotherapy (MRgRT) into a Prostate Cancer Program will allow to reproduce the results obtained with state-of-the-art brachytherapy combined with EBRT with the added advantage of convenience.

Who can participate

Age range18 Years – 80 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with unfavorable intermediate, high and very high risk PCa as per the NCCN stratification criteria . * Suboptimal candidates for high-dose therapy such as elderly, frail patients or patients with large volume glands (i.e, \>60cm3) or extensive TURP in the prior 6-12 months should be considered cautionary indications. * Patients with low risk of nodal spread may be treated on a MRI-guided local SBRT program. Exclusion Criteria: * No prior radiation therapy to the target areas * Patient able to undergo a MRI exam

What they're measuring

Biochemical relapse-free survival

Timeframe: 5-years

Trial details

NCT IDNCT07132073

SponsorClinica Universidad de Navarra, Universidad de Navarra

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2030-06-30

View on ClinicalTrials.gov More Prostate Cancer trials